Literature DB >> 15157873

Phosphoinositide signaling; from affinity probes to pharmaceutical targets.

Glenn D Prestwich1.   

Abstract

Lipid signaling by phosphoinositides (PIP(n)s) involves an array of proteins with lipid recognition, kinase, phosphatase, and phospholipase functions. Understanding PIP(n) pathway signaling requires identification and characterization of PIP(n)-interacting proteins. Moreover, spatiotemporal localization and physiological function of PIP(n)-protein complexes must be elucidated in cellular and organismal contexts. For protein discovery to functional elucidation, reporter-linked phosphoinositides or tethered PIP(n)s have been essential. The phosphoinositide 3-kinase (PI 3-K) signaling pathway has recently emerged as an important source of potential "druggable" therapeutic targets in human pathophysiology in both academic and pharmaceutical environments. This review summarizes the chemistry of PIP(n) affinity probes and their use in identifying macromolecular targets. The process of target validation will be described, i.e., the use of tethered PIP(n)s in determining PIP(n) selectivity in vitro and in establishing the function of PIP(n)-protein complexes in living cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157873     DOI: 10.1016/j.chembiol.2004.03.025

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  35 in total

Review 1.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

2.  The GABA(A) receptor as a target for photochromic molecules.

Authors:  Mariel Feliciano; Devaiah Vytla; Kathryne A Medeiros; James J Chambers
Journal:  Bioorg Med Chem       Date:  2010-06-01       Impact factor: 3.641

3.  Subunit composition and role of Na+,K+-ATPases in adrenal chromaffin cells.

Authors:  Hai Lin; Shoichiro Ozaki; Naoji Fujishiro; Kazuo Takeda; Issei Imanaga; Glenn D Prestwich; Masumi Inoue
Journal:  J Physiol       Date:  2005-02-03       Impact factor: 5.182

4.  Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate.

Authors:  Yong Xu; Stephanie A Lee; Tatiana G Kutateladze; Diego Sbrissa; Assia Shisheva; Glenn D Prestwich
Journal:  J Am Chem Soc       Date:  2006-01-25       Impact factor: 15.419

Review 5.  Regulation of ATP-gated P2X receptors by phosphoinositides.

Authors:  Qi Zhao; Diomedes E Logothetis; Philippe Séguéla
Journal:  Pflugers Arch       Date:  2007-05-04       Impact factor: 3.657

6.  ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Homer Fenner; Assia Shisheva
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

7.  Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.

Authors:  Kedar S Vaidya; Sitaram Harihar; Pushkar A Phadke; Lewis J Stafford; Douglas R Hurst; David G Hicks; Graham Casey; Daryll B DeWald; Danny R Welch
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

8.  Catalyst-Dependent Syntheses of Phosphatidylinositol-5 Phosphate-DiC8 and its Enantiomer.

Authors:  Katherine J Kayser-Bricker; Peter A Jordan; Scott J Miller
Journal:  Tetrahedron       Date:  2008-07-14       Impact factor: 2.457

9.  5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.

Authors:  Honglu Zhang; Ju He; Tatiana G Kutateladze; Takahiro Sakai; Takehiko Sasaki; Nicolas Markadieu; Christophe Erneux; Glenn D Prestwich
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164

10.  Microplate-based characterization of protein-phosphoinositide binding interactions using a synthetic biotinylated headgroup analogue.

Authors:  Denghuang Gong; Matthew D Smith; Debasis Manna; Heidi E Bostic; Wonhwa Cho; Michael D Best
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.